Cisbio Bioassays is a global developer of products, technologies and services used in drug discovery, and a reference provider of immunoassays for in vitro diagnostics. HTRF®, its proprietary technology, is a widely used assay platform implemented by the pharmaceutical industry for high throughput screening. Cisbio Bioassays is a subsidiary of the IBA group.
IBA group develops and markets leading edge technologies, pharmaceuticals and tailor-made solutions for healthcare, with a special focus on cancer diagnosis and therapy. The company is also active in the field of industrial sterilization and ionization, with decades of scientific expertise in health-related hygiene and safety. Headquartered in Belgium, IBA is present in more than 40 countries in North America, Europe and Asia, and employs 2100 professionals.